Hopp til hovedinnhold

Stenting av koronararterier

Sist revidert:
Sist revidert av:


  1. Bønaa K, Mannsverk J, Wiseth R, et al. Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. New Engl J Med 2016; 375: 1242-1252. doi:10.1056/NEJMoa1607991 DOI  
  2. Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med. 2013;368(3):254-265. PubMed  
  3. Juel J, Jensen SE. Trombose i koronarstent ved behandling med clopidogrel og protonpumpeinhibitorer. Ugeskr Læger 2011; 173: 654. Ugeskrift for Læger  
  4. Park SJ, Park DW, Kim YH, et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med 2010; 362: 1374-82. PubMed  
  5. Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2008; 118: 1894-1909. Circulation  
  6. King SB III, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008; 51: 172-209. PubMed  
  7. Gibson CM, Mehran R, Bode C, et al. . Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med 2016. doi:10.1056/NEJMoa1611594 DOI  
  • Ingard Løge, spesialist allmennmedisin, redaktør NEL